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Introduction
Urticaria is a dermatological disorder that manifests as raised 
erythematous lesions that range in size. They are pruritic and 
typically resolve with no changes to the appearance of the 
skin. Urticarial lesions may be associated with episodes of 
swellings known as ‘angioedema’. The role of infection as a 
potential trigger for urticaria and angioedema is well described 
but the precise mechanism by which infection induces release of 
histamine from mast cells is unknown. Infections, including 
dental infections, have been associated with urticaria; however, 
current chronic urticaria guidelines do not recommend routine 
screening for underlying infection1,2. Instead, they advise tar-
geted investigations, based on the clinical history and examina-
tion findings. We report a case of severe chronic spontaneous 
urticaria that rapidly resolved following root canal treatment.
Case report
A 19-year-old male patient was referred to the Immunology clinic 
by his General Practitioner (GP). He presented with a two-month 
history of urticaria with intermittent episodes of angioedema. His 
initial symptoms included facial pruritis, periorbital erythema 
and angioedema involving the upper and lower lips. Within 
30 minutes of his first episode of angioedema, he developed 
widespread urticaria which responded to treatment with antihis-
tamines. The following day, he experienced a recurrence of the 
symptoms and continued to have almost daily symptoms of 
urticaria with intermittent episodes of angioedema. He was 
commenced on an alternative anti-histamine by his GP but 
continued to develop urticaria and experience swellings of the 
hands and feet. His treatment was escalated at his initial visit to 
Immunology Clinic to fexofenadine 180mg twice a day with an 
additional 10–20mg of cetirizine. In addition, montelukast, a 
leukotriene receptor antagonist, was commenced.
The number of hives and degree of pruritis were graded using 
an objective scoring system known as the Urticaria Activity 
Score 7 (UAS7) that provides a weekly average score out of a 
maximum score of 42. The patient recorded weekly UAS7 scores 
of 30, despite treatment with maximum doses of antihistamines 
and montelukast. Therefore, Anti-IgE therapy with the mono-
clonal antibody ‘Omalizumab’ was offered. In the interim, he 
presented to his dentist with a broken tooth and was found to 
have carious molars requiring root canal treatment. One week 
after this intervention, his UAS7 score fell to 4 and then to 0, 
and he has remained in remission (UAS 7 score 0) for 9 months. 
As he was rather needle-phobic, he was delighted that this 
obviated the need for Omalizumab injections. Initial inves-
tigations including full blood count, renal function, liver 
function and thyroid function tests were all within the normal 
ranges.
Discussion
Chronic spontaneous urticaria (CSU) is defined as daily or 
almost daily urticaria for at least 6 weeks1. In up to 50% 
of patients, urticaria may be associated with episodes of 
angioedema3. These features are the result of degranulation of 
mast cells with the release of granule contents, predominantly 
histamine. Patients often present to their GP and are referred for 
further assessment and management by Immunologists, Aller-
gists or Dermatologists when first line treatment with antihista-
mines fail to control the symptoms. The mainstay of treatment is 
high dose antihistamines and leukotriene receptor antagonists1. 
In recent years, the anti-IgE monoclonal antibody therapy, 
Omalizumab, has been used as an effective treatment for patients 
who fail to respond to first and second line therapy.
In cases of CSU, triggers such as food-based allergens or 
airborne allergens are rarely implicated4. In acute urticaria 
(defined as having a duration of less than 6 weeks), causes are 
more likely to be identified. In one study of 79 cases of acute 
urticaria, 36.7% were secondary to infection5.
A number of studies have demonstrated an increased prevalence 
of oropharyngeal infections including dental infections, sinusi-
tis and tonsillitis in patients with chronic urticaria3,6,7. An early 
study from 1964 demonstrated radiological evidence of focal 
dental infection in 29% of their cohort of patients with chronic 
urticaria3. In addition, cases have been reported of resolution 
of urticaria after treatment of dental infections8,9. In one case 
bacterial cultures from dental lesions grew the gram-negative 
bacteria Veillonella parvula10. It is thought that Lipopolysac-
charide from gram negative bacteria induces an inflammatory 
response characterised by histamine release from mast cells and 
resulting urticaria11.
Other infections reported to be associated with CSU include 
Helicobacter pylori which is known to have immunomodula-
tory effects12. However, H. pylori eradication in CSU patients 
has had mixed results13–15. Infection with viral hepatitis has also 
been associated with CSU16,17 and guidelines suggest performing 
a hepatitis screen if transaminases are abnormal1. However, 
a systematic review on the subject revealed that the prevalence 
of hepatitis B and hepatitis C was no greater in CSU patients 
than compared with the general population18.
The presented case history demonstrates the close temporal 
relationship between treatment of dental infection and the 
improvement of urticaria and reduction in medication require-
ments. Inflammatory markers were not monitored in this case but 
may have been elevated19. Measurement of markers of the acute 
inflammatory response, including CRP, can easily be included 
in assessment of patients with chronic urticaria. Together with a 
careful history, an elevation in acute inflammatory markers, may 
highlight the presence of infection/inflammation. Where infec-
tion has been excluded, the elevated inflammatory markers may 
identify patients with more severe chronic urticaria20.
Our patient had failed first and second line treatments for 
chronic urticaria with persistent and troublesome symptoms. 
      Amendments from Version 2
We have made some minor changes. The maximum UAS7 score 
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With a UAS 7 >28, demonstrating poorly controlled chronic 
urticaria, he was eligible to commence anti-IgE therapy21. 
Monoclonal antibody anti-IgE treatment with Omalizumab is 
now provided by some immunology and dermatology units in the 
UK. Patients are given Omalizumab by sub-cutaneous injec-
tion once a month for 6 months, and their response is monitored 
throughout. Although relatively safe, any new treatment is 
not without the risk of side effects. In addition, the treatment is 
costly, and should be reserved for patients who have severe 
CSU that fail to respond to treatment with the maximum dose of 
anti-histamine treatment and leukotriene receptor antagonists.
Our case history illustrates the importance of searching for 
infections, including odontogenic infections, prior to commencing 
immunosuppression or anti-IgE therapy in patients who are 
resistant to first line treatment of CSU.
Consent
Written informed consent was obtained from the patient for the 
publication of their clinical details.
Data availability
No data is associated with this article.
Grant information
The author(s) declared that no grants were involved in supporting 
this work.
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